Absolute Investment Advisers »

Fs Global Cr Opportunitie Fda shares owned by Absolute Investment Advisers

Quarter-by-quarter ownership of Fs Global Cr Opportunitie Fda (FSCO) shares owned by Absolute Investment Advisers from 13F filings

Historical chart of Absolute Investment Advisers investment in Fs Global Cr Opportunitie Fda

Tip: Access up to 7 years of quarterly data

All positions including Fs Global Cr Opportunitie Fda held by Absolute Investment Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fs Global Cr Opportunitie Fda by Absolute Investment Advisers

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.0M 314k 6.36

More positions owned by Absolute Investment Advisers

Granite Constr Note 3.250% 6/1
Patrick Inds Note 1.750%12/0
Halozyme Therapeutics Note 1.000% 8/1
Osi Systems Note 2.250% 8/0
Liberty All Star Equity Sh Ben Int (USA)
Tetra Tech DBCV 2.250% 8/1
Wayfair Note 3.250% 9/1
Fluor Corp Note 1.125% 8/1
MKS Note 1.250% 6/0
Greenbrier Cos Note 2.875% 4/1
Fluence Energy Note 2.250% 6/1
Ani Pharmaceuticals Note 2.250% 9/0
Parsons Corp Del Note 2.625% 3/0
Akamai Technologies Note 1.125% 2/1
Guidewire Software Note 1.250%11/0

View all positions for Absolute Investment Advisers

Top funds holding Fs Global Cr Opportunitie Fda

Commonwealth Equity Services
Cambridge Investment Research Advisors
Sit Investment Associates
Cetera Investment Advisers
LPL Financial
Vista Finance
Thomas J. Herzfeld Advisors
Blackstone Group
Envestnet Asset Management
Rockefeller Capital Management
Advisor Group Holdings
Summit Financial
Deschutes Portfolio Strategy
Ellis Investment Partners
Advisors Asset Management

View all funds holding Fs Global Cr Opportunitie Fda